A change to the normal training camp routine has Ben Johnson talking to press prior to practice, and at least for the moment the alteration can have merit.

The Speaker had said he wanted full transparency, but now he’s shut down the House to spare Trump from such demands.

Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shed light on. Cramer was incredibly bullish on the company as he said: “Now, sometimes in this game, you do just get lucky. You’ll come across a surprise quarter that tells you everything you need to know about what can cause a big

Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish technical momentum. Learn more on JNJ stock here.

Johnson says he wants to put social workers at stops and launch an anti-smoking campaign. A council member who’s pushed for enforcement against smoking says the mayor’s ideas could lack teeth.

Johnson & Johnson ( ($JNJ) ) has released its Q2 earnings. Here is a breakdown of the information Johnson & Johnson presented to its investors.

Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to Johnson & Johnson’s portfolio.